Does Recursion Pharmaceuticals (RXRX) Pay a Dividend? (2026)
Short answer
Recursion Pharmaceuticals (RXRX) pays a dividend with an approximate yield of Not profitable; pays no dividend as of early 2026, typically quarterly. A dividend is a slice of profits returned to shareholders, and the yield is that payout divided by the share price, so it drifts as both change. Figures here are approximate; verify the current number with your broker.
Does Recursion Pharmaceuticals (RXRX) pay a dividend?
Yes. Recursion Pharmaceuticals distributes an approximate Not profitable; pays no dividend yield (early 2026), usually quarterly. Because Recursion is pre-profit with minimal revenue, traditional earnings multiples do not apply, and the figures that matter most are cash on hand, the rate of cash burn, and how long the runway lasts before the company must raise money again. Q1 2026 showed narrower losses driven by sizable cuts to R&D and overhead, which extended the stated runway into early 2028, but revenue came in well below analyst expectations. For a story like this, valuation is ultimately a bet on future platform output and partnership milestones rather than on current financial performance.
How to think about RXRX's dividend
- Yield is a snapshot: Not profitable; pays no dividend today, but it moves with price and payout.
- Total return vs income: dividends are one part of return; price change is usually the bigger part for a name like RXRX.
- Reinvest or take income: a DRIP compounds; taking the cash gives income now.
- For more yield: dedicated dividend stocks and ETFs target higher payouts. See the best dividend ETFs.
The bottom line on the RXRX dividend
Recursion Pharmaceuticals (RXRX) pays an approximate Not profitable; pays no dividend dividend, so it offers some income but is held mostly for total return, not yield. For the full picture see the RXRX guide. Walnut can show how RXRX fits your real portfolio. It is not an investment adviser.
Build a basket around RXRX with Walnut
Use Recursion Pharmaceuticals as one constituent in a thematic basket Walnut's AI helps you assemble. Describe a thesis you believe in, the AI proposes the holdings and weights, and you approve before any broker order.
FAQ
Does Recursion Pharmaceuticals (RXRX) pay a dividend?
+
Recursion Pharmaceuticals has an approximate dividend yield of Not profitable; pays no dividend (early 2026). Yields move with price and payout, so treat this as a recent snapshot and verify the current figure with your broker or RXRX's investor relations page.
What is RXRX's dividend yield?
+
Approximately Not profitable; pays no dividend as of early 2026 (approximate, verify). Remember a higher yield is not automatically better: it can reflect a falling share price as much as a generous payout.
How often does RXRX pay its dividend?
+
US companies that pay dividends, like Recursion Pharmaceuticals if it does, typically distribute them quarterly. Confirm the exact schedule and ex-dividend dates on RXRX's investor relations page before relying on the timing.
Can I reinvest RXRX dividends?
+
Yes. Most brokers offer automatic dividend reinvestment (a DRIP) so any RXRX dividend buys more shares automatically. It compounds over time but is still taxable in a taxable account.
Is RXRX a good dividend stock?
+
Walnut is informational, not investment advice. With an approximate Not profitable; pays no dividend yield, RXRX is more of a growth or total-return name than a high-yield one. Dedicated dividend stocks and ETFs target higher, steadier yield; match the choice to whether you want income now or growth.
Does RXRX pay a dividend?
+
No. Recursion does not pay a dividend and is not expected to. As an unprofitable, cash-burning clinical-stage company, it directs all available capital toward research, clinical trials, and its computing platform rather than returning cash to shareholders. Investors in a stock like this are betting on potential future share-price appreciation, not income.
Walnut is informational, not investment advice. Dividend figures are approximate and dated; verify current yield, schedule, and policy with RXRX's investor relations page or your broker.